Please login to the form below

Not currently logged in
Email:
Password:

Galbraith settles with Cohn & Wolfe

Rebecca Galbraith has settled court proceedings issued by global public relations agency Cohn & Wolfe, where she used to be board director

Rebecca Galbraith has settled court proceedings issued by the global public relations agency Cohn & Wolfe (C&W), where she was previously a board director.

Galbraith had been dismissed on grounds of gross misconduct a month after she handed in her notice at the agency.

In the proceedings at the high court, C&W alleged that Galbraith "acted in breach of contract and fiduciary duty by misappropriating proprietary information belonging to Cohn & Wolfe and preparing to actively compete with the agency while sitting as a board director."

As reported in PR Week, Galbraith said: "Firstly I wish to apologise unreservedly to Cohn & Wolfe and WPP for my actions, but secondly I wish to the apologise to the Cohn & Wolfe team in London."

She continued: "I accept my conduct was in breach of my legal obligations. I acknowledge I removed proprietary information belonging to Cohn & Wolfe but confirm that I did not open or disseminate that information to any third parties."

Galbraith has paid an undisclosed settlement. Her apology follows those of fellow former board directors, Fiona McMillan, who settled out of court on April 20 and, Jeremy Clark, who settled out of court on April 16.

4th May 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Running
A marathon and a sprint
Customer experience is a long-distance race and with pharma late out of the blocks, companies need to put their foot down if they want to compete...
5 tactics to master Market Access
Is it time to rethink your game plan? To succeed at Market Access, follow these 5 tactics:...
Finding the patient voice
How patients feel and speak about clinical trials...

Infographics